Insiders Opthea Limited

Equities

Market Closed - Australian S.E. Other stock markets 11:40:37 17/05/2024 am IST			5-day change	1st Jan Change
0.63 ^AUD	-5.97%		-0.79%	+10.53%

03/04	Opthea Limited Announces Board Changes	CI
29/02	Opthea Posts H1 FY24 Loss per Share of $0.1623; R&D Expenses Jump	MT

Opthea Limited Announces Board Changes	04/04	CI
Opthea Appoints Chief Medical Advisor; Shares Decline 4%	20/02	MT
Opthea Appoints Arshad M. Khanani as Chief Medical Advisor	20/02	CI
Opthea Makes Management Appointments As Part of Next Stage Drug Trial; Shares Up 13%	02/02	MT
Opthea Strengthens Team with Key Clinical and Regulatory Hires	01/02	CI
Opthea Limited Appoints Peter Lang as Chief Financial Officer	27/23/27	CI
Opthea Limited Announces Transition of Megan Baldwin to Founder and Chief Innovation Officer, Effective October 27, 2023	27/23/27	CI
Opthea Limited Announces Executive Changes	27/23/27	CI
Opthea Selects Name for Eye Medication Candidate	27/23/27	MT
Opthea Limited Announces ?Sozinibercept? as the Nonproprietary Drug Name for OPT-302	26/23/26	CI
Opthea Appoints Senior Medical Adviser	11/23/11	MT
Opthea's Chief Medical Officer Joel Naor Resigns	10/23/10	MT
Opthea Limited Announces Executive Changes	10/23/10	CI
Opthea Limited Appoints Anshul Thakral as Non-Executive Director of the Board	08/23/08	CI
Opthea Appoints CFO	25/22/25	MT
Opthea Appoints Timothy Morris as CFO	24/22/24	MT
Opthea Limited Appoints Timothy E. Morris as Chief Financial Officer	24/22/24	CI
Imugene Appoints CFO	18/22/18	MT
Opthea Limited Announces Board Appointments	21/22/21	CI
Opthea Names New Chief Medical Officer; Shares Decline 7%	03/22/03	MT

No results for this search